Literature DB >> 35946755

Concomitant Use of Ranolazine and Trimetazidine in Patients with Refractory Angina: An Initial Experience.

Luciana Oliveira Cascaes Dourado1, Cristian Paul Delgado Moreno1, Sarah Fagundes Grobe1, Luis Henrique Wolff Gowdak1, Luiz Antonio Machado Cesar1.   

Abstract

Entities:  

Year:  2022        PMID： 35946755      PMCID： PMC9563874          DOI： 10.36660/abc.20210711

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN： 0066-782X            Impact factor:   2.667


× No keyword cloud information.
  8 in total

1.  The effectiveness of intensive medical treatment in patients initially diagnosed with refractory angina.

Authors:  Luciana Oliveira Cascaes Dourado; Nilson Tavares Poppi; Eduardo Leal Adam; Thiago Nunes Pereira Leite; Alexandre da Costa Pereira; José Eduardo Krieger; Luiz Antonio Machado Cesar; Luís Henrique Wolff Gowdak
Journal:  Int J Cardiol       Date:  2015-03-17       Impact factor: 4.164

2.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Stephan D Fihn; Julius M Gardin; Jonathan Abrams; Kathleen Berra; James C Blankenship; Apostolos P Dallas; Pamela S Douglas; Joanne M Foody; Thomas C Gerber; Alan L Hinderliter; Spencer B King; Paul D Kligfield; Harlan M Krumholz; Raymond Y K Kwong; Michael J Lim; Jane A Linderbaum; Michael J Mack; Mark A Munger; Richard L Prager; Joseph F Sabik; Leslee J Shaw; Joanna D Sikkema; Craig R Smith; Sidney C Smith; John A Spertus; Sankey V Williams
Journal:  J Am Coll Cardiol       Date:  2012-11-19       Impact factor: 24.094

Review 3.  The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina.

Authors:  C Mannheimer; P Camici; M R Chester; A Collins; M DeJongste; T Eliasson; F Follath; I Hellemans; J Herlitz; T Lüscher; M Pasic; D Thelle
Journal:  Eur Heart J       Date:  2002-03       Impact factor: 29.983

4.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

Authors:  Juhani Knuuti; William Wijns; Antti Saraste; Davide Capodanno; Emanuele Barbato; Christian Funck-Brentano; Eva Prescott; Robert F Storey; Christi Deaton; Thomas Cuisset; Stefan Agewall; Kenneth Dickstein; Thor Edvardsen; Javier Escaned; Bernard J Gersh; Pavel Svitil; Martine Gilard; David Hasdai; Robert Hatala; Felix Mahfoud; Josep Masip; Claudio Muneretto; Marco Valgimigli; Stephan Achenbach; Jeroen J Bax
Journal:  Eur Heart J       Date:  2020-01-14       Impact factor: 29.983

5.  Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.

Authors:  José López Sendón; Stella Lee; Mei L Cheng; Ori Ben-Yehuda
Journal:  Eur J Prev Cardiol       Date:  2012-06-11       Impact factor: 7.804

Review 6.  The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials.

Authors:  Song Peng; Min Zhao; Jing Wan; Qi Fang; Dong Fang; Kaiyong Li
Journal:  Int J Cardiol       Date:  2014-10-24       Impact factor: 4.164

Review 7.  Expert consensus document: A 'diamond' approach to personalized treatment of angina.

Authors:  Roberto Ferrari; Paolo G Camici; Filippo Crea; Nicolas Danchin; Kim Fox; Aldo P Maggioni; Athanasios J Manolis; Mario Marzilli; Giuseppe M C Rosano; José L Lopez-Sendon
Journal:  Nat Rev Cardiol       Date:  2017-09-07       Impact factor: 32.419

8.  Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry).

Authors:  Katelyn M Storey; Julia Wang; Ross F Garberich; Noel M Bennett; Jay H Traverse; Theresa L Arndt; Christian W Schmidt; Timothy D Henry
Journal:  Am J Cardiol       Date:  2020-05-16       Impact factor: 2.778
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.